Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.

MLA

Gupta, Milan, et al. “Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.” Cardiology and Therapy, vol. 12, no. 4, Dec. 2023, pp. 703–22. EBSCOhost, https://doi.org/10.1007/s40119-023-00334-5.

APA

Gupta, M., Wani, R. J., Al Faraidy, K., Bergeron, J., Contreras, E., Peña, A. A. G., Mancini, G. B. J., Padilla, F., Lopez, A. A. P., Philip, K., Wu, J., & Mackinnon, E. S. (2023). Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study. Cardiology and Therapy, 12(4), 703–722. https://doi.org/10.1007/s40119-023-00334-5

Chicago

Gupta, Milan, Rajvi J Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras, Angel Alberto Garcia Peña, G B John Mancini, et al. 2023. “Real-World Insights into Evolocumab Use in Patients with Hyperlipidemia Across Five Countries: Analysis from the ZERBINI Study.” Cardiology and Therapy 12 (4): 703–22. doi:10.1007/s40119-023-00334-5.